Abstract:Background: Drug shortages significantly threaten public health and medical service provision worldwide. Research evidence on the complete picture of drug shortages is currently scant in China. This study aimed to provide a descriptive overview and a reference for alleviating of drug shortages in China. Methods: National and provincial lists of drug shortages issued in China from 2018 to 2021 were collected and summarized. The information on essential medicines, medical insurance drugs, emergency drugs, and volume-based purchasing drugs was then matched with a drug shortage list to analyse the characteristics, proportion and incidence of drug shortage on each list based on the analysis of information such as dosage form, shortage frequency, and Anatomical Therapeutic Chemical (ATC) classification of the drugs in shortage. Results: A total of 24 provinces issued drug shortages lists involving 408 drugs from 2018 to 2021. All 58 drugs in the national drug list were included on the provincial drug shortage list. Among all the drugs in shortage, the most significant shortage involved injections, accounting for 45.3% (185/408). Ninety-five drugs (23.3%) were in shortage 5 times (annual shortage > 1 time) or more in the provincial lists, and 199 drugs (48.8%) were on the shortage list only once. In terms of therapeutic property, nearly all categories of drugs had been reported in shortage, among which cardiovascular drugs, nervous system drugs, anti-tumor and immunomodulatory drugs, and blood and hematopoietic organ drugs accounted for more than 10%. There is no significant difference in drug shortage among economic regions. Comparing drugs in shortage and various lists, 81.9% (334/408), 51.0% (208/408) and 67.9% (277/408) fell on the National Medical Insurance Drug List, National Essential Medicines List, and WHO Model List of Essential Medicines, respectively, while the volume-based purchasing drugs accounted for 3.4% (14 drugs). The incidence of drug shortages on NEML, WHO Model List of Essential Medicines and medical insurance category A was significantly higher than that of medical insurance category B and volume-based purchasing drugs (P < 0.05). Of the Emergency Drugs List, 72.0% (36/50) also experienced shortages, significantly higher than all the above categories (P < 0.05). Conclusions: In China, drug shortages were severe and complicated. Drug shortages vary among economic regions but are not significant. In comparison, the national procurement pattern of volume-based drug purchasing may be conducive to alleviating the drug shortage problem. Collaboration of all partners was recommended to ensure the supply of clinically necessary drugs.

Survey and Analysis on Drug Shortage in China

Investigation and Analysis of the Reasons for Drug Shortage from 26 Medical Institutions in China

A Review of Research on Drug Shortages in China

Drug supply and assurance: a cross-sectional study of drug shortage monitoring varieties in China

Drug shortages in China: a cross-sectional study

Analysis and Suggestions on current situation of Chinese Drug Shortage Problem

Trends of Drug Shortages in China from 2018 to 2020: A Retrospective Observational Study

Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study

The Current Status and Effects of Emergency Drug Shortages in China: Perceptions of Emergency Department Physicians

International Experiences of Response to Medicines Shortage and the Implications to China

Evidence-based Evaluation of Monitoring System for Global Short Drugs

The impact of drug shortages on drug prices: evidence from China

Analysis of the current situation of the shortage of antitumor drugs in medical insti-tutions in Shaanxi Province

Study on the supply and security of essential drugs in primary medical institutions in poor areas

Demand analysis of drugs outside the list of national essential medicines and Shanghai supplementary drugs in the community health centers of Shanghai

Whether medicine supply is really meeting primary health care needs: a mixed-methods study in Shandong Province, China

Investigation of the Availability and Accessibility of Essential Drugs Based on Experience Abroad

Empirical Study on Availability of Essential Medicine in China

Establishment and Application of an Index System for the Risk of Drug Shortages in China: Based on Delphi Method and Analytic Hierarchy Process

Study on the Current Status and Intervention Measures of Essential Medicine in Short Supply